ArticleCancers2026

Repurposing Alkylating Agents in Melanoma via ERCC8 Silencing: A Novel Therapeutic Strategy.

Silvia Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.